References

  1. Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005; 100(1):162-8. PubMed | Google Scholar

  2. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002; 38 (5): 39-51. PubMed | Google Scholar

  3. Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR. Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study. Mod. Pathol 2005; 18(4): 475-484. PubMed | Google Scholar

  4. Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M et al. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet. 2008; 16(1): 79-88. PubMed | Google Scholar

  5. Grass N, Cipolla C, Torcivia A, Mandalà S, Graceffa G, Bottino A et al. Gastrointestinal stromal tumour of the rectum: Report of a case and review of literature. World J Gastroenterol. 2008; 14(8): 1302-1304. PubMed | Google Scholar

  6. Samlani-Sebbane Z, Diffaa A , Charaf K. ,Rabbani K , Narjis Y , El Mansouri F et al. Le GIST rectal : à propos de deux observations et une revue de la littérature. J Afr Hépatol Gastroentérol. 2011; 5(1): 60-62. PubMed | Google Scholar

  7. Hou Y, Zhou Y, Lu S, Qi W, Xu Ch, Hou J et al,. Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor. World J Gastroenterol. 2009; 15(15): 1910-1913. PubMed | Google Scholar

  8. Vander Noot MR, Eloubeidi MA, Chen VK, Eltoum I, Jhala D, Jhala N et al. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound guided fine-needle aspiration biopsy. Cancer. 2004; 102(3): 157-163. PubMed | Google Scholar

  9. Emile JF, Bachet JB, Tabone-Eglinger S , Brahimi S. Histologie et pathologie moléculaire des tumeurs stromales gastrointestinales (GIST). Revue francophone des laboratoires. 2008; 2008(398) : 53-58. PubMed | Google Scholar

  10. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST): update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007; 5 (2): 1-29. PubMed | Google Scholar

  11. Casali PG, Blay JYESMO Guidelines Working Group. Gastrointestinal stromal tumors:22 ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21 (5): 98-102.. PubMed | Google Scholar

  12. Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010; 8 (2): 1-41.. PubMed | Google Scholar

  13. Dong C, Jun-Hui C, Xiao-Jun Y et al. Gastrointestinal stromal tumors of the rectum: clinical, pathologic, immunohistochemical characteristics and prognostic analysis. Scand J Gastroenterol. 2007; 42(10): 1221-9. PubMed | Google Scholar

  14. Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009; 373(9669): 1097-1104. PubMed | Google Scholar

  15. Van Glabbeke MM, Owzar K, Rankin C, Simes J, Crowley J, Group GM-a. Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors (GIST): A meta-analyis based on 1640 patients. J Clin Oncol. 2010 Mar 1;28(7):1247-53. PubMed | Google Scholar